This MAPrc study will examine important safety aspects (such as agitation,
aggression and depression) of the drugs varenicline and bupropion
compared to placebo (“dummy pills” that do not contain any medicine) and
nicotine-replacement therapy (NRT or “the patch”) in smokers with or
without a history of being diagnosed with a psychiatric disorder. See
more: Link
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.